stat.MEOct 31, 2026

Accuracy Is Not Risk: Why Medical AI Should Not Report Only Its Most Likely Label

Authors: Jeffrey Humpherys, Makoto Jones

Organizations: Department of Mathematics and Statistics, Missouri University of Science and Technology · Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine

Abstract

Background. Many medical AI models are trained to reproduce a single reference label and hand the most likely label to the next step in a clinical workflow. A classifier can select that label correctly while providing an inadequate summary for estimating downstream risk. Methods. We use Jeffrey's rule of conditioning to specify when probabilities over intermediate states, such as diagnoses or imaging categories, can be carried forward to an outcome risk. We separate two errors of reporting only the most likely label, discarding the probability of the other states and applying the risk of patients who have the leading diagnosis to a patient who only probably has it. We also give conditions under which the label and the full distribution lead to the same decision, and we propose guardrails for device developers, regulatory reviewers, and health insurers. Results. In a hypothetical chest-pain differential, reporting only the benign leading diagnosis greatly understates the patient's risk of death or cardiac arrest, so a patient who warrants evaluation could be discharged or denied imaging. In a hypothetical BI-RADS example, the most likely category is "probably benign," yet the propagated malignancy risk exceeds the ceiling that defines that category. Conclusions. A predicted label is not an observed state, and a calibrated classifier is not automatically a valid outcome model. Clinical and insurance coverage decisions should rest on the patient's outcome risk, judged against a threshold justified by the consequences of acting and not acting. Developers should state what each model output means and check that every step between the model and the decision preserves the patient's risk.

Figures & tables

Appendix figures & tables1 asset

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Sep 30, 2026

OmniMed-Jev: Calibrating LVLM Confidence for Trustworthy Medical Multimodal Decisions via System One

Medical models are judged not only on correctness, but on whether reported confidence matches actual accuracy. Generalist multimodal medical models have expanded what a single model can perceive, yet they still express bounded decisions such as diagnoses, findings or cell counts as generated text, so the reported probability reflects the next token rather than the decision itself. Motivated by decision-native interfaces such as Jev, we introduce OmniMed-Jev, which represents each medical decision as a Choice, Noul or Score decision over a runtime-supplied candidate set and returns a full distribution over that set: mutually exclusive classes, binary presence of a finding, or a bounded ordered value. The design is omni in three respects: it accepts diverse imaging modalities, covers different prediction tasks, and expresses them through one candidate-conditioned probability model, so heterogeneous outputs become comparable probabilities rather than task-specific strings. In an interface-controlled comparison against a generative baseline trained on the same backbone, data and schedule, OmniMed-Jev's reported probabilities track observed correctness far more closely, reducing calibration error by up to an order of magnitude and reliability error by up to two, while point-prediction performance remains comparable; counting is the one family where the generative baseline stays ahead. Making the decision distribution the model's output is not a format change but what turns reported numbers into probabilities that mean what they say. These results support explicit decision modeling as a way to make reported confidence meaningful within the evaluated tasks, and they are not evidence of clinical readiness: the comparison cannot separate the interface from associated training differences, which we state alongside the results. Code is available at github.com/lytang63/OmniMed-Jev.
Sep 28, 2026

Unknown is not normal: separating language-model extraction from rule-based decision logic for clinical risk scores

Large language models (LLMs) are increasingly used to compute clinical risk scores from free-text notes. Notes are often incomplete, and treating undocumented findings as normal can silently misclassify patients. We test whether separating three-state extraction (present, absent or unknown, by an LLM) from decision logic (deterministic code computing score bounds over unknown inputs) lets a system ask only questions that can change the decision. On 1,200 synthetic emergency cases across six calculators (HEART, CURB-65, qSOFA, PERC, Wells, Cockcroft-Gault), with a simulated clinician answering questions, we compared this bounds policy with asking for every missing input, a missing-equals-normal schema, and an end-to-end LLM agent (Claude Opus 5.5). With Claude Haiku 4.5 as extractor, the bounds policy matched ask-all accuracy (99.4% vs 99.4%) with half the questions (0.92 vs 1.78 per case) and no irrelevant ones. Treating missing as normal dropped accuracy to 91.2% and under-triaged 8.5% of patients (95% CI 7.1-10.2), and under-triage persisted under messy notes and a noisy clinician. The agent was equally accurate under ideal conditions (99.6%) but 9.5% of its questions were irrelevant; with a noisy clinician it was less accurate than the bounds policy (83.5% vs 87.0%, p<0.001) and committed prematurely in 2.7% of cases (bounds: 0%). A 9B local model as extractor reached oracle-level accuracy (99.8%). In 584 real case reports from MedCalc-Bench, only 52% contained enough information to determine the category (HEART 13%). Routing decisions through code that reasons explicitly about unknowns avoids premature commitment and irrelevant questions, halves the questions asked, and works with small local models.
Nov 9, 2026

Certify, Report, or Refuse: Harm-Constrained Conformal Prediction for Clinical Actions

Routing a melanoma case to routine follow-up is a serious action error that diagnostic coverage alone does not rule out. We present Harm-Constrained Risk-Optimal Conformal Prediction (HC-ROCP), a training-free framework that uses frozen classifier probabilities and adds a harm penalty when choosing prediction sets and actions. We test the resulting policies on disjoint calibration splits with multiplicity adjustment. HC-ROCP certifies supported claims, reports descriptive fallback policies, and refuses unsupported subgroup claims. We evaluate these outputs retrospectively on COVID-19 radiographs, ISIC 2019 dermoscopy, and EyePACS-to-APTOS retinopathy transfer. Across ten calibration seeds, HC-ROCP reduces COVID-19 severe-action errors from the exact risk-optimal baseline's 4.68% to 0.54%. At a 5% budget, global claims are certified for COVID-19 and ISIC, but the rare squamous-cell-carcinoma claim is refused. At 1%, all settings receive descriptive reports. For each budget, we also report the minimum severe-case count needed to pass the global harm gate with zero errors, providing a starting point for further data collection.